![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Adoptive Transfer of Zinc Finger Nuclease CCR5 Modified Autologous CD4 T-cells (SB-728-T) to Aviremic HIV-infected Subjects with Suboptimal CD4 Counts (200-500 cells/mm3)
|
|
|
Reported by Jules Levin
ICAAC Chicago Sept 17-20
Ronald Mitsuyasu1, Jacob Lalezari2, Steven Deeks3, Shelley Wang4, Gary Lee4, Michael Holmes4, Philip Gregory4, Marty Giedlin4, Winson Tang4 and Dale Ando41UCLA, Los Angeles, CA; 2Quest Clinical Research, San Francisco, CA; 3UCSF, San Francisco, CA; and 4Sangamo BioSciencesInc, Richmond, CA;
ICAAC: Sangamo HIV Gene Therapy Data Reported at ICAAC Sept 19 2011 - (09/21/11)
ICAAC: HIV Gene Therapy Safe, Well Tolerated - (09/21/11)
ICAAC: Zinc Finger-Modified CD4-Cell Booster Transplant Working in Pilot Trial - Written by Mark Mascolini - (09/19/11)
![ICAAC1.gif](../images/092211/092211-2/ICAAC1.gif)
![ICAAC2.gif](../images/092211/092211-2/ICAAC2.gif)
![ICAAC3.gif](../images/092211/092211-2/ICAAC3.gif)
![ICAAC4.gif](../images/092211/092211-2/ICAAC4.gif)
![ICAAC5.gif](../images/092211/092211-2/ICAAC5.gif)
![ICAAC6.gif](../images/092211/092211-2/ICAAC6.gif)
![ICAAC7.gif](../images/092211/092211-2/ICAAC7.gif)
![ICAAC8.gif](../images/092211/092211-2/ICAAC8.gif)
![ICAAC9.gif](../images/092211/092211-2/ICAAC9.gif)
![ICAAC10.gif](../images/092211/092211-2/ICAAC10.gif)
![ICAAC11.gif](../images/092211/092211-2/ICAAC11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|